John Heymach, M.DNovember 5, 2021

FDA 483 - John Heymach, M.D - November 05, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore John Heymach, M.D

Record Details

An FDA inspection of John Heymach, M.D. in Houston, TX, identified a significant deviation from an investigational plan. The inspection revealed multiple instances where investigational product was infused into subjects at a faster rate than specified by the study protocol. This raises concerns regarding patient safety and drug efficacy.

Company: John Heymach, M.D
Inspection Date: November 5, 2021
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West III
Person: Anya D. Lockett-Evans

Open in Dashboard

ID · 416dff3c-7092-4563-96e4-113ba1ca8ae1